A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
14
50g/day divided in 3. Breakfast, lunch and dinner
Centre de recherche sur le vieillissement
Sherbrooke, Quebec, Canada
Cognition
Measure of cognition with CANTAB
Time frame: 2 months, evaluation before and after intervention
Ketones
Measurement of ketones concentrations
Time frame: 2 months, evaluation before and after intervention
Endocannabinoids
Endocannabinoids plasma concentration
Time frame: 2 months, evaluation before and after intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.